Your session is about to expire
← Back to Search
Learning Communities for PTSD
N/A
Waitlist Available
Led By Norman Shields, PhD
Research Sponsored by Ryerson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients must have a diagnosis of PTSD
Patients must be 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.
Awards & highlights
Study Summary
This trial will compare the effectiveness of two different approaches to delivering evidence-based care for PTSD in three different mental health systems.
Who is the study for?
This trial is for adults with PTSD who are clients of therapists willing to use Cognitive Processing Therapy (CPT). Therapists must agree to treat 6 patients over 2 years, be open to random assignment in the study, record sessions, and have internet access. Excluded are those with uncontrolled psychotic/bipolar disorders, substance dependence, immediate suicide/homicide risk, or significant cognitive impairment.Check my eligibility
What is being tested?
The study compares two strategies aimed at sustaining and improving the delivery of CPT for PTSD within three mental health systems. It evaluates if these approaches affect patient outcomes and clinician skills differently across varying environments.See study design
What are the potential side effects?
Since this trial involves psychotherapy rather than medication, traditional 'side effects' aren't applicable. However, participants may experience emotional discomfort or distress as a natural part of therapy addressing traumatic experiences.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with PTSD.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be followed for an expected duration of 12 weeks of therapy. pcl-5 will be measured at baseline, at weeks 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, post-treatment week, and at 3-month follow-up.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in PTSD Symptoms over 6 months (PCL-5 measure)
Secondary outcome measures
CPT Activity Reporting
Content-Level and Context-Level Adaptation
Fidelity Measure
Trial Design
2Treatment groups
Experimental Treatment
Group I: Quality Improvement Learning CommunityExperimental Treatment1 Intervention
The Quality Improvement Learning Community arm will include clinicians who set goals related to CPT delivery, execute a plan, study results, refine plan, and continue each cycle until goals are met.
Group II: Fidelity-oriented Learning CommunityExperimental Treatment1 Intervention
The Fidelity-oriented Learning Community arm will receive fidelity consultation (adherence and competence) feedback by a CPT expert via online meetings.
Find a Location
Who is running the clinical trial?
National Center for PTSDFED
12 Previous Clinical Trials
981 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,602 Total Patients Enrolled
Palo Alto Veterans Institute for ResearchOTHER
52 Previous Clinical Trials
7,815 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing to have my sessions recorded.I agree to provide treatment to 6 patients over 2 years.I have been diagnosed with PTSD.I am 18 years old or older.I am a clinician providing therapy to PTSD patients.
Research Study Groups:
This trial has the following groups:- Group 1: Quality Improvement Learning Community
- Group 2: Fidelity-oriented Learning Community
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger